Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The miR-205 response elements on VEGFA mRNA are specific regulatory sequences located within the 3' untranslated region (3' UTR) of the Vascular Endothelial Growth Factor A (VEGFA) transcript (Wu et al., 2016, PMID: 26848621). These elements serve as the primary binding sites for microRNA-205 (miR-205), which acts as a post-transcriptional repressor of VEGFA expression. By recruiting the RNA-induced silencing complex (RISC), miR-205 binding leads to either the degradation of the VEGFA mRNA or the inhibition of its translation into protein (Hu et al., 2016, PMID: 27167194). This interaction plays a critical role in controlling angiogenesis, as VEGFA is a major driver of blood vessel formation and vascular permeability. In many cancers, such as breast and prostate cancer, miR-205 is frequently downregulated, resulting in the loss of this inhibitory control and subsequent VEGFA-mediated tumor vascularization (Greene et al., 2010, PMID: 20802488). Similarly, in ocular diseases like neovascular age-related macular degeneration, modulating these response elements offers a potential therapeutic pathway to reduce pathological vessel growth (Yan et al., 2018, PMID: 30128485). Experimental therapies, including miR-205 mimics and antisense oligonucleotides, are being explored to target these sites to restore normal VEGFA regulation.
Binding of microRNA mimics to the response element recruits the RNA-induced silencing complex (RISC), leading to mRNA degradation or translational inhibition of VEGFA.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular endothelial growth factor A messenger RNA microRNA-205 response element (VEGFA miR-205 RE) (VEGFA miR-205 RE).